Showing 1581-1590 of 3742 results for "".
Unpacking the Latest CMS Proposal
https://practicaldermatology.com/topics/practice-management/unpacking-the-latest-cms-proposal/20349/What might these changes mean for dermatologists?The Colemans: Dermatology as a Father-Son(s) Tradition
https://practicaldermatology.com/topics/feature/colemans-dermatology-father-sons-tradition/26956/The Colemans: Dermatology as a Father-Son(s) TraditionUnderstanding the SGR: An Explainer
https://practicaldermatology.com/topics/practice-management/understanding-the-sgr-an-explainer/21194/How did the SGR come to be? If it goes away, what will happen to the misplaced focus on physician payments?Squamoid Eccrine Ductal Carcinoma: A Diagnostic Challenge
https://practicaldermatology.com/youngmd-connect/resident-resource-center/squamoid-eccrine-ductal-carcinoma-a-diagnostic-challenge/23970/Squamoid eccrine ductal carcinoma is often initially misdiagnosed as squamous cell carcinoma.Optimizing Approaches to Rejuvenation
https://practicaldermatology.com/topics/practice-management/optimizing-approaches-to-rejuvenation/21036/Insights from DermTube.com about the latest approaches to cosmetic dermatology.Well-Known “Novel” Therapeutic Option for Molluscum Contagiosum
https://practicaldermatology.com/topics/general-topics/well-known-novel-therapeutic-option-for-molluscum-contagiosum/20946/DermwireTV — Sun Rises, ICD-10 is Delayed…Again
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-sun-rises-icd-10-is-delayed-again/19139/In this week's DermwireTV, Sun acquires Ranbaxy, ICD-10 gets unexpectedly delayed, and Murad Alam recaps the ASLMS conference.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesDermwireTV — Revance’s Neurotoxin Promising, Celebs Fight Melanoma with L’Oreal
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-revance-rsquo-s-neurotoxin-promising-celebs-fight-melanoma-with-l-rsquo-oreal/19138/In this weeks DermwireTV, patient safety is explored, L'Oreal supports melanoma research and Revance reports positive data for novel neurotoxin.DermwireTV — Nestle acquires Galderma; Dermatologic procedures surge
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-nestle-acquires-galderma-dermatologic-procedures-surge/19157/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine: Nestle acquires Galderma, dermatologic procedures surge, and we look ahead to the annual meeting in Denver. #DermWire